5ml Ampoule Washing Sterilizing Filling Sealing Line Auto Fault Diagnostics, 20000 pcs/h Dry-Heat Sterilization AGF-8S

Traditional ampoule processing lines require separate floor-level utility trenches for water, compressed air, natural gas and electrical services, consuming 12-15 square meters of cleanroom floor space for infrastructure alone. For facilities producing 5ml products in ISO 7 environments, this infrastructure cost represents 25-30% of total line capital expenditure before any production equipment is installed.

Cleanroom floor space carries a construction cost of $4000-8000 per square meter for ISO 7 classification including HVAC, raised flooring and wall panel systems. Every square meter of equipment footprint in a cleanroom represents $12,000-24,000 in total facility investment when including the proportional share of air handling, utilities and gowning areas. Compact integrated equipment directly reduces cleanroom capital expenditure.

Our compact monoblock architecture for the 5ml ampoule line integrates all utilities within the machine chassis, with internal cable trays, water manifolds and gas distribution pipes pre-plumbed and factory-tested. The complete line occupies 6.5-10m * 1.8m of cleanroom floor space—a 40-50% reduction versus separate machines—saving approximately $45,000-95,000 in cleanroom construction costs per installation based on ISO 7 facility build rates.

• Vertical Ultrasonic Ampoule Washing: 12 independently-controlled 31kHz piezoelectric transducers generate cavitation fields reaching every internal surface of inverted ampoules. Post-wash clarity rate exceeds 99% as verified by inline 5MP camera inspection with 360° rotation capture.
• Independent Water and Air Rinsing Channels: Four dedicated WFI rinsing needles and four 0.2μm-filtered compressed-air drying needles plumbed through separate 316L stainless steel manifolds. Cross-contamination between channels is physically impossible with PTFE-encapsulated seals at every junction.
• Dry-Heat Sterilization and Depyrogenation: CFD-optimized laminar-flow tunnel at 310-325°C with HEPA H14 filtration achieves validated 3-log endotoxin reduction. Three independently-controlled heating zones with 36 thermocouple inputs enable real-time thermal mapping and automated deviation response.
• Laminar-Flow Hot Air Circulation: Uniform 0.5 m/s ±0.05 m/s face velocity across the entire sterilization tunnel cross-section, verified by 16-point anemometer grid mapping during IQ/OQ. ISO 5 particle classification maintained throughout the tunnel length under dynamic operating conditions.
• Servo-Driven ±0.5% Filling Accuracy: Ceramic piston pumps (Al₂O₃ 99.7%) with 17-bit absolute encoders deliver closed-loop volumetric dosing. Integrated in-line checkweighing at 0.1mg resolution provides 100% fill verification with automatic rejection of out-of-specification ampoules.
• Synchronized Filling and Flame Sealing: Servo-controlled Z-axis nozzle retraction and burner ignition synchronized at 1ms update rate with ±0.5ms timing precision. 2-color IR pyrometer (200Hz) provides real-time glass temperature feedback for dynamic burner height adjustment at 0.05mm resolution.

For 5ml ampoule production at 20000 pcs/h, this model suits facilities producing 160-320k ampoules per single/double shift. Select this capacity tier when your annual demand falls between 40-80 million ampoules. For start-up or clinical trial supply with lower initial volumes, consider our 10000 pcs/h variant. For high-volume commercial manufacturing, step up to the 30000 pcs/h model. Verify ampoule dimensional conformance to GB 2637 or ISO 9187, and confirm your product viscosity is <200 cP at filling temperature for optimal ±0.5% accuracy.

Suitable for pharmaceutical injectable products requiring aseptic processing in 5ml ampoule format. Ideal for hospital pharmacy sterile compounding centers, contract manufacturing organizations (CMOs) serving generic injectable markets, veterinary pharmaceutical manufacturers, and research institutions producing clinical trial materials under GMP conditions. Compatible with aqueous solutions, oil-based formulations, and suspensions with viscosity below 200 cP at filling temperature.

Q: Is the line compatible with CIP/SIP systems?
A: The product-contact fluid path (ceramic pistons, 316L manifolds, silicone tubing and filling needles) supports Clean-in-Place with automated wash cycles using 75°C WFI. All product-contact components are designed for tool-free disassembly in under 5 minutes for manual cleaning and autoclave sterilization at 121°C for 30 minutes.

Q: What glass particulate control measures are in place?
A: Five-layer defense: (1) dual-frequency ultrasonic washing removes >99.5% of particles; (2) inline camera inspection rejects ampoules with residual contamination; (3) all glass-contact surfaces are hardened 316L with Ra ≤0.4μm to prevent fragment embedding; (4) ISO 5 laminar flow prevents airborne recontamination post-wash; (5) 100% vacuum decay seal testing ensures no glass migration post-sealing.

Q: What utility requirements must the facility provide?
A: Water for Injection (WFI) at 2.5 bar and 65°C ±2°C with <1.3 μS/cm conductivity; compressed air at 6 bar, oil-free, filtered to 0.01μm with dew point ≤-40°C; natural gas (or propane) at 50 mbar for flame sealing; 380V/50Hz 3-phase electrical supply, 25-45 kVA depending on tunnel length; clean dry compressed air for pneumatics at 6 bar. All utility consumption rates are specified in the installation qualification documentation.

Q: What is the typical IQ/OQ/PQ validation timeline?
A: Site acceptance testing requires 5-7 working days covering mechanical commissioning, sterilization cycle verification with biological indicators (Bacillus atrophaeus spores), and three consecutive media-fill runs per ISO 13408-1. A complete validation documentation package with executed protocols and raw data is provided.